{
    "organizations": [],
    "uuid": "20664bddeea233fe532d55e399e20c1f74d3c7bf",
    "author": "",
    "url": "https://www.reuters.com/article/brief-endocyte-announces-phase-3-vision/brief-endocyte-announces-phase-3-vision-trialprovides-update-on-corporate-strategy-and-reports-q4-and-2017-financial-results-idUSASB0C7EH",
    "ord_in_thread": 0,
    "title": "BRIEF-Endocyte Announces Phase 3 Vision Trial,Provides Update On Corporate Strategy And Reports Q4 And 2017 Financial Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 22 PM / Updated 6 minutes ago BRIEF-Endocyte Announces Phase 3 Vision Trial,Provides Update On Corporate Strategy And Reports Q4 And 2017 Financial Results Reuters Staff 1 Min Read Feb 26 (Reuters) - Endocyte Inc: * ENDOCYTE ANNOUNCES PHASE 3 VISION TRIAL AND PROVIDES UPDATE ON CORPORATE STRATEGY AND REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $0.18 * ANNOUNCED AGREEMENT FOR CLINICAL SUPPLY OF NO-CARRIER-ADDED LUTETIUM WITH ITM * CAR T-CELL THERAPY EXPECTED TO BEGIN CLINICAL DEVELOPMENT IN Q4 OF 2018 * ‍ ENROLLMENT OF VISION TRIAL IS EXPECTED TO BEGIN IN Q2 OF 2018 AND IS EXPECTED TO BE COMPLETED IN 18-24 MONTHS​ * CASH, CASH EQUIVALENTS & INVESTMENTS WERE $97.5 MILLION AT DEC. 31, 2017, VERSUS $103.1 MILLION AT SEPT. 30, 2017 * ‍ FIRST INTERIM ASSESSMENT OF OS FOR VISION TRIAL COULD OCCUR AS EARLY AS SECOND HALF OF 2019​ * ANTICIPATES ITS CASH, CASH EQUIVALENTS AND INVESTMENTS BALANCE AT END OF 2018 TO EXCEED $50 MILLION * HAS SUFFICIENT CASH TO FUND ITS ACTIVITIES INTO SECOND HALF OF 2019 THROUGH MANY IMPORTANT MILESTONES  ",
    "published": "2018-02-26T15:21:00.000+02:00",
    "crawled": "2018-02-26T15:39:41.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "phase",
        "vision",
        "trial",
        "provides",
        "update",
        "corporate",
        "strategy",
        "report",
        "q4",
        "financial",
        "result",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "endocyte",
        "inc",
        "endocyte",
        "announces",
        "phase",
        "vision",
        "trial",
        "provides",
        "update",
        "corporate",
        "strategy",
        "report",
        "fourth",
        "quarter",
        "year",
        "end",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "announced",
        "agreement",
        "clinical",
        "supply",
        "lutetium",
        "itm",
        "car",
        "therapy",
        "expected",
        "begin",
        "clinical",
        "development",
        "q4",
        "enrollment",
        "vision",
        "trial",
        "expected",
        "begin",
        "q2",
        "expected",
        "completed",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "versus",
        "million",
        "first",
        "interim",
        "assessment",
        "o",
        "vision",
        "trial",
        "could",
        "occur",
        "early",
        "second",
        "half",
        "anticipates",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "balance",
        "end",
        "exceed",
        "million",
        "sufficient",
        "cash",
        "fund",
        "activity",
        "second",
        "half",
        "many",
        "important",
        "milestone"
    ]
}